Pathology of prolactin cell adenomas of the human pituitary.
Prolactin (PRL) cell adenoma is the most common tumor type in the human pituitary. It accounts for 30% of surgically removed adenomas, while its prevalence is even higher (45%) among incidental pituitary tumors observed at autopsy. Most PRL cell adenomas are highly differentiated with a characteristic ultrastructure. Administration of bromocriptine, a dopaminergic agonist, evokes profound morphologic changes in responsive PRL cell adenomas, while it leaves the fine structure of unresponsive tumors unchanged. The importance of immunocytochemical and electron microscopic investigation of pituitary biopsies is emphasized as tumors with different cell derivation, biological behavior, and therapeutic responsiveness may mimic PRL cell adenomas clinically.
Horvath
E
E
Kovacs
K
K
D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D000328:Adult; D003594:Cytoplasmic Granules / Q000648:ultrastructure; D005089:Exocytosis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008854:Microscopy, Electron; D009361:Neoplasm Invasiveness; D010902:Pituitary Gland / Q000473:pathology; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D011388:Prolactin / Q000378:metabolism*
D011388:Prolactin